Skip to content

Park‑Pagliuca Fund donates $10M to PolyBio Long COVID Cure Initiative

scienceApr 27, 2026340

The Park-Pagliuca Fund donated $10 million to the PolyBio Long COVID Cure Initiative to accelerate diagnostics and therapies for Long COVID. The gift will fund biomarker validation work, including VIPER, a program to validate tests that detect and quantify SARS-CoV-2 persistence and other biological drivers such as immune dysregulation. The LCCI core team will use the funding to build a national, diagnostics-guided clinical trials network to fast-track trials that match patients to targeted treatments. Faster diagnostics and a coordinated trials network will translate those biological insights into targeted therapies, shortening recovery for millions and improving care for neurocognitive and reproductive sequelae of Long COVID.

3 sources